WHO ICTRP trial
A randomized, double-blind, placebo-controlled trial to investigate the efficacy…
EUCTR2018-003370-27-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2018-003370-27-GB |
|---|---|
| Public title | A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of cannabidiol oral solution (GWP42003-P; CBD-OS) in patients with Rett syndrome. |
| Scientific title | A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of cannabidiol oral solution (GWP42003-P; CBD-OS) in patients with Rett syndrome. |
| Primary sponsor | GW Research Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;France;Canada;Spain;Australia;Italy;United Kingdom |
| Conditions | Rett syndrome (RTT) [typical or atypical] MedDRA version: 20.0 Level: PT Classification code 10077709 Term: Rett syndrome System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Nervous… |
| Interventions | Trade Name: CBD - Oral Solution, is known as Epidyolex, and is the approved name in the USA. Product Name: Cannabidiol (CBD) Product Code: GWP42003-P Pharmaceutical Form: Oral solution INN or Proposed INN: Cannabidiol CAS Number: 13956-29-1… |
| Registration date | Dec 24, 2018 |
| Target size | 252 |
| Secondary IDs | GWND18064 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: